Exploring the role of testosterone upon adiposity and cardiovascular risk markers in men with severe obesity

Abstract

A prominent endocrine disorder linked to unhealthy lifestyle behaviors and increased visceral adiposity is Male Obesity Secondary Hypogonadism (MOSH). The pathogenesis of MOSH remains under investigation. However, recent evidence supports a direct role of leptin in affecting Leydig cells, reducing testosterone production, and increasing appetite. Conversely, testosterone deficiency is associated with comorbidities like hypertension, diabetes, and nonalcoholic fatty liver disease. A recently published study entitled “Relationship between sex hormones, markers of adiposity and inflammation in male patients with severe obesity undergoing bariatric surgery” describes evidence supportive of an inverse association between testosterone and serum leptin as well as levels of c-reactive protein (CRP) and IL-6, as well as a correlation between body mass index and CRP. The same study also provides novel insight retrieved from their in vitro findings, which reveal that testosterone exposure influences the expression of genes associated with adiposity, like fatty acid binding protein 4, peroxisome proliferation-activated receptor γ (PPARγ), leptin, and adiponectin, as well as von Willebrand factor, in human-derived adipocytes. Overall, the latest evidence highlights the importance of early identification of hypogonadism in obese males and the potential benefits of testosterone supplementation in alleviating complications associated with obesity, particularly chronic inflammation. These observations underscore the need for a holistic approach to managing severe obesity, addressing hormonal and inflammatory factors to reduce its overall burden on health.

Keywords

Testosterone / male obesity secondary hypogonadism / adipocytes / von Willebrand factor

References

[1] Fernandez CJ,Pappachan JM.Male obesity-related secondary hypogonadism-pathophysiology, clinical implications and management.Eur Endocrinol2019;15:83-90 PMCID:PMC6785957

[2] Leisegang K,Agarwal A.Obesity and metabolic syndrome associated with systemic inflammation and the impact on the male reproductive system.Am J Reprod Immunol2019;82:e13178

[3] Stanford FC,Kyle TK.Media and its influence on obesity.Curr Obes Rep2018;7:186-92 PMCID:PMC5959781

[4] Camacho EM,O'Neill TW.Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study.Eur J Endocrinol2013;168:445-55

[5] Shi Z,Martin S,Wittert GA.Longitudinal changes in testosterone over five years in community-dwelling men.J Clin Endocrinol Metab2013;98:3289-97

[6] Escobar-Morreale HF,Luque-Ramírez M.Prevalence of 'obesity-associated gonadal dysfunction' in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis.Hum Reprod Update2017;23:390-408

[7] Corona G,Huhtaniemi I.European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology.Andrology2020;8:970-87

[8] Calderón B,Vega-Piñero B.Prevalence of male secondary hypogonadism in moderate to severe obesity and its relationship with insulin resistance and excess body weight.Andrology2016;4:62-7

[9] Wu FC,Pye SR.Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study.J Clin Endocrinol Metab2008;93:2737-45

[10] Bellastella G,Puliani G,Savastano S.How much does obesity affect the male reproductive function?.Int J Obes Suppl2019;9:50-64 PMCID:PMC6683183

[11] Rubinow KB.Estrogens and body weight regulation in men. In: Mauvais-jarvis F, editor. Sex and gender factors affecting metabolic homeostasis, diabetes and obesity. Cham: Springer International Publishing; 2017. pp. 285-313. PMCID:PMC5835337

[12] Dhindsa S,Vora M,Chaudhuri A.Low estradiol concentrations in men with subnormal testosterone concentrations and type 2 diabetes.Diabetes Care2011;34:1854-9 PMCID:PMC3142021

[13] Saboor Aftab SA, Kumar S, Barber TM. The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism.Clin Endocrinol2013;78:330-7

[14] Cohen PG.Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging connection.Med Hypotheses2001;56:702-8.

[15] Birzniece V.Gonadal steroids and body composition, strength, and sexual function in men.N Engl J Med2013;369:2455

[16] Xu X,Ye J.The effect of aromatase on the reproductive function of obese males.Horm Metab Res2017;49:572-9

[17] Schulster M,Ramasamy R.The role of estradiol in male reproductive function.Asian J Androl2016;18:435-40 PMCID:PMC4854098

[18] Quennell JH,Tups A.Leptin indirectly regulates gonadotropin-releasing hormone neuronal function.Endocrinology2009;150:2805-12. PMCID:PMC2732287

[19] Marcouiller F,Ganouna-Cohen G.Metabolic responses to intermittent hypoxia are regulated by sex and estradiol in mice.Am J Physiol Endocrinol Metab2021;320:E316-25 PMCID:PMC8260369

[20] Carrageta DF,Alves MG.Obesity and male hypogonadism: tales of a vicious cycle.Obes Rev2019;20:1148-58

[21] Genchi VA,Lauriola C.Adipose tissue dysfunction and obesity-related male hypogonadism.Int J Mol Sci2022;23:8194 PMCID:PMC9330735

[22] Dimopoulou C,Corona G.The complex association between metabolic syndrome and male hypogonadism.Metabolism2018;86:61-8.

[23] Mangiola S,McCoy P.Androgen deprivation therapy promotes an obesity-like microenvironment in periprostatic fat.Endocr Connect2019;8:547-58. PMCID:PMC6499921

[24] Kim S,Park JH.A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease.BMC Gastroenterol2012;12:69 PMCID:PMC3406998

[25] Stellato RK,Hamdy O,McKinlay JB.Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study.Diabetes Care2000;23:490-4

[26] Di Vincenzo A,Granzotto M.Relationship between sex hormones, markers of adiposity and inflammation in male patients with severe obesity undergoing bariatric surgery.Metab Target Organ Damage2023;3:12

[27] Kawai T,Scalia R.Adipose tissue inflammation and metabolic dysfunction in obesity.Am J Physiol Cell Physiol2021;320:C375-91 PMCID:PMC8294624

[28] Liu L,Ji X.Adipokines, adiposity, and atherosclerosis.Cell Mol Life Sci2022;79:272

[29] Koliaki C,Kokkinos A.Obesity and cardiovascular disease: revisiting an old relationship.Metabolism2019;92:98-107

[30] Corona G,Di Pasquale G,Mannucci E.Endogenous testosterone levels and cardiovascular risk: meta-analysis of observational studies.J Sex Med2018;15:1260-71

[31] Dhindsa S,Sethi M,Chaudhuri A.Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes.J Clin Endocrinol Metab2004;89:5462-8

[32] Grossmann M.Low testosterone in men with type 2 diabetes: significance and treatment.J Clin Endocrinol Metab2011;96:2341-53

[33] Wittert G,Robledo KP.Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.Lancet Diabetes Endocrinol2021;9:32-45

[34] Robledo KP,Handelsman DJ.Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the testosterone for prevention of type 2 diabetes mellitus trial.Eur J Endocrinol2023;188:613-20.

[35] Deepika F,Colleluori G.Baseline testosterone predicts body composition and metabolic response to testosterone therapy.Front Endocrinol2022;13:915309 PMCID:PMC9309506

[36] Haider KS,Saad F.Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study.Diabetes Obes Metab2020;22:2055-68

[37] Yassin A,Haider KS.Testosterone therapy in men with hypogonadism prevents progression from prediabetes to type 2 diabetes: eight-year data from a registry study.Diabetes Care2019;42:1104-11

[38] Arrese M,Arab JP.Sarcopenia in the setting of nonalcoholic fatty liver.Metab Target Organ Damage2022;2:2.

[39] Nasr P,Ekstedt M.Non-metabolic causes of steatotic liver disease.Metab Target Organ Damage2023;3:19

[40] Alqahtani SA.Administration of testosterone improves the prothrombotic and antifibrinolytic parameters associated with its deficiency in an orchidectiomized rat model.Platelets2019;30:624-30.

[41] De Pergola G,Sciaraffia M.Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.Metabolism1997;46:1287-93.

[42] Spiel AO,Jilma B.von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes.Circulation2008;117:1449-59

[43] Palhinha L,Hottz ED.Leptin induces proadipogenic and proinflammatory signaling in adipocytes.Front Endocrinol2019;10:841. PMCID:PMC6923660

[44] Astapova O.Chapter Six - Adiponectin and PPARγ: cooperative and interdependent actions of two key regulators of metabolism. Adiponectin. Elsevier; 2012. pp. 143-62.

[45] Shan T,Kuang S.Fatty acid binding protein 4 expression marks a population of adipocyte progenitors in white and brown adipose tissues.FASEB J2013;27:277-87. PMCID:PMC3528316

[46] Yang W,Luo J,Wang W.Adiponectin promotes preadipocyte differentiation via the PPARγ pathway.Mol Med Rep2018;17:428-35.

[47] Lee JE,Lai B.Transcriptional and epigenomic regulation of adipogenesis.Mol Cell Biol2019;39:e00601-18 PMCID:PMC6517598

[48] Ghaben AL.Adipogenesis and metabolic health.Nat Rev Mol Cell Biol2019;20:242-58

[49] Prentice KJ,Robertson LT.A hormone complex of FABP4 and nucleoside kinases regulates islet function.Nature2021;600:720-6 PMCID:PMC8983123

[50] Trombley S,Schmitz M.Sex steroids stimulate leptin gene expression in Atlantic salmon parr hepatocytes in vitro.Gen Comp Endocrinol2015;221:156-64.

[51] Dieudonne MN,Boumediene A,Giudicelli Y.Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids.Am J Physiol1998;274:C1645-52

[52] De Pergola G, Xu XF, Yang SM, Giorgino R, Bjorntorp P. Up-regulation of androgen receptor binding in male rat fat pad adipose precursor cells exposed to testosterone: study in a whole cell assay system.J Steroid Biochem Mol Biol1990;37:553-8.

[53] Xu X,Björntorp P.The effects of androgens on the regulation of lipolysis in adipose precursor cells.Endocrinology1990;126:1229-34

[54] Horenburg S,Debatin KM.Influence of sex hormones on adiponectin expression in human adipocytes.Horm Metab Res2008;40:779-86